» Authors » Aubrey M Moe

Aubrey M Moe

Explore the profile of Aubrey M Moe including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 39
Citations 130
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Moe A, Blain S, Kalathil A, Peltier S, Colombi C, Thakkar K, et al.
Psychol Med . 2025 Mar; 55:e67. PMID: 40025690
Background: Mentalizing-our ability to make inferences about the mental states of others-is impaired across psychiatric disorders and robustly associated with functional outcomes. Mentalizing deficits have been prominently linked to aberrant...
2.
Tran I, Trask C, Moe A
Psychiatr Serv . 2025 Feb; :appips20240313. PMID: 39980363
Social support improves outcomes for individuals after first-episode psychosis (FEP). Illness-related changes in social behavior (e.g., social anxiety, withdrawal, and stigma) may hinder such individuals' comfort with in-person interactions; however,...
3.
Kemp K, Tso I, Taylor S, Moe A
Schizophr Res . 2025 Feb; 276:167-174. PMID: 39892250
Schizophrenia-spectrum disorders have been associated with heightened stress sensitivity, which can worsen prognosis, functioning, and quality of life. However, more research is needed to determine whether different types of stress...
4.
Moe A, Wastler H, Breitborde N
Early Interv Psychiatry . 2024 Oct; 18(11):975-976. PMID: 39403744
No abstract available.
5.
Moe A, Llamocca E, Wastler H, Steelesmith D, Brock G, Oluwoye O, et al.
Schizophr Bull Open . 2024 Aug; 5(1):sgae019. PMID: 39206276
Background: Despite recognition that early intervention for first-episode psychosis (FEP) improves outcomes, Black youth with FEP continue to experience critical disparities in care. A historical lack of scientific focus on...
6.
Moe A, Cowan H, Manges M, Wastler H, Hamilton S, Kilicoglu M, et al.
Early Interv Psychiatry . 2024 Jul; 18(10):888-893. PMID: 38986532
Aim: Despite increasingly refined tools for identifying individuals at clinical high-risk for psychosis (CHR-P), less is known about the effectiveness of CHR-P interventions. The significant clinical heterogeneity among CHR-P individuals...
7.
Wastler H, Mengda Y, Pan X, Bornheimer L, Moe A, Breitborde N
Psychiatry Res . 2024 Jun; 338:115978. PMID: 38823163
This study examined trajectories of suicide-risk and their relationship to symptoms, recovery, and quality of life over time. Data was obtained from the Recovery after an Initial Schizophrenia Episode Early...
8.
Kilicoglu M, Lundin N, Angers K, Moe A
Behav Sci (Basel) . 2024 Apr; 14(4). PMID: 38667061
Metacognitive functioning-which broadly encompasses the mental processes involved in thinking about the thinking of one's self and the thinking of others-is often impaired among individuals living with schizophrenia and may...
9.
Lundin N, Blouin A, Cowan H, Moe A, Wastler H, Breitborde N
Psychol Res Behav Manag . 2024 Mar; 17:1365-1383. PMID: 38529082
Early detection of psychotic-spectrum disorders among adolescents and young adults is crucial, as the initial years after psychotic symptom onset encompass a critical period in which psychosocial and pharmacological interventions...
10.
Hamilton S, Wastler H, Moe A, Cowan H, Lundin N, Guirgis H, et al.
Psychiatr Serv . 2023 Dec; 75(5):496-499. PMID: 38088038
Validated, multicomponent treatments designed to address symptoms and functioning of individuals at clinical high risk for psychosis are currently lacking. The authors report findings of a study with such individuals...